Skip to main content
Clinical Trials/NCT04276324
NCT04276324
Completed
Not Applicable

Effects of Ten-Weeks Resistance Training on Neuromuscular Performance, Heart Rate Variability, Sleep Quality and Mobility in Persons With Multiple Sclerosis

Universidad Católica San Antonio de Murcia1 site in 1 country36 target enrollmentMarch 10, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Universidad Católica San Antonio de Murcia
Enrollment
36
Locations
1
Primary Endpoint
Spasticity
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Multiple Sclerosis (ME) is a degenerative, inflammatory and autoimmune demyelinating disease of the central nervous system, characterized by demyelination due to inflammation and degeneration of the myelin sheaths enveloping nerves of the eye, periventricular grey matter, brain, spinal cord and brainstem. The symptoms associated with MS include symptomatic fatigue, muscle weakness, ataxia, mobility and balance problems or cognitive problems. Strength training has been shown to improve strength and mobility in persons with MS.

Registry
clinicaltrials.gov
Start Date
March 10, 2020
End Date
October 15, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Universidad Católica San Antonio de Murcia
Responsible Party
Principal Investigator
Principal Investigator

Jacobo Á. Rubio

Principal Investigator

Universidad Católica San Antonio de Murcia

Eligibility Criteria

Inclusion Criteria

  • mild or moderate disability with clinical mild spastic-ataxic gait disorder.
  • stable phase of the disease.

Exclusion Criteria

  • Expanded Disability Status Scale (EDSS) \<
  • relapsing disease within the preceding 12 months.
  • corticosteroid treatment within the last months before study inclusion.

Outcomes

Primary Outcomes

Spasticity

Time Frame: After 10 weeks

Pendulum test

Maximal Voluntary Isometric Contraction of Knee Extension

Time Frame: After 10 weeks

Rate of Force Development

Time Frame: After 10 weeks

Central Activation Ratio

Time Frame: After 10 weeks

Secondary Outcomes

  • Walking speed(After 10 weeks)
  • Static balance(After 10 weeks)
  • Functional capacity(After 10 weeks)
  • Heart Rate Variability(After 10 weeks)
  • Sleep Quality(After 10 weeks)

Study Sites (1)

Loading locations...

Similar Trials